1 results match your criteria: "Hanzhong 3201 Hospital Affiliated to Xi'anJiaotong University[Affiliation]"
BRCA1 and STMN1 as prognostic markers in NSCLCs who received cisplatin-based adjuvant chemotherapy.
Oncotarget
October 2017
Department of Pathology, Hanzhong 3201 Hospital Affiliated to Xi'anJiaotong University, Xi'an, Shaanxi, China.
Objective: In this study, we aimed to investigate the predictive effect of , , and on the prognosis of patients with non-small cell lung cancer (NSCLC).
Methods: Seventy NSCLC patients who received platinum-based chemotherapy from June 2009 to July 2011 were enrolled. The protein and mRNA levels of , , and were determined.